Chemoinformaics analysis of (E)-linalool oxide
Molecular Weight | 170.252 | nRot | 2 |
Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
Exact Molecular Weight | 170.131 | nRing | 1 |
Solubility: LogS | -0.974 | nHRing | 1 |
Solubility: LogP | 1.985 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 30.3063 |
nHD | 1 | BPOL | 19.7937 |
QED | 0.641 |
Synth | 4.037 |
Natural Product Likeliness | 3.614 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.244 |
MDCK | 0.0000277 |
BBB | 0.739 |
PPB | 0.453116 |
VDSS | 1.355 |
FU | 0.509581 |
CYP1A2-inh | 0.025 |
CYP1A2-sub | 0.657 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.858 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.105 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.17 |
CYP3a4-inh | 0.189 |
CYP3a4-sub | 0.36 |
CL | 7.412 |
T12 | 0.451 |
hERG | 0.011 |
Ames | 0.024 |
ROA | 0.586 |
SkinSen | 0.649 |
Carcinogencity | 0.65 |
EI | 0.939 |
Respiratory | 0.823 |
NR-Aromatase | 0.021 |
Antiviral | No |
Prediction | 0.942706 |